The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies release_dolq63xu2fd2pipls33o3luhs4

by Antonella Fattorusso, Sara Matricardi, Elisabetta Mencaroni, Giovanni Battista Dell'Isola, Giuseppe Di Cara, Pasquale Striano, Alberto Verrotti

Published in Frontiers in Neurology by Frontiers Media SA.

2021   Volume 12

Abstract

Epilepsy is one of the most common neurological chronic disorders, with an estimated prevalence of 0. 5 – 1%. Currently, treatment options for epilepsy are predominantly based on the administration of symptomatic therapy. Most patients are able to achieve seizure freedom by the first two appropriate drug trials. Thus, patients who cannot reach a satisfactory response after that are defined as pharmacoresistant. However, despite the availability of more than 20 antiseizure medications (ASMs), about one-third of epilepsies remain drug-resistant. The heterogeneity of seizures and epilepsies, the coexistence of comorbidities, and the broad spectrum of efficacy, safety, and tolerability related to the ASMs, make the management of these patients actually challenging. In this review, we analyze the most relevant clinical and pathogenetic issues related to drug-resistant epilepsy, and then we discuss the current evidence about the use of available ASMs and the alternative non-pharmacological approaches.
In application/xml+jats format

Archived Files and Locations

application/pdf   381.2 kB
file_ubj7opdwqbeuncbylnddqyug3a
fjfsdata01prod.blob.core.windows.net (web)
web.archive.org (webarchive)

Web Captures

https://www.frontiersin.org/articles/10.3389/fneur.2021.674483/full
2022-06-15 22:15:04 | 28 resources
webcapture_vlkoi5iuvvcvjdsw5tekacuv7y
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2021-06-22
Container Metadata
Open Access Publication
In DOAJ
In ISSN ROAD
In Keepers Registry
ISSN-L:  1664-2295
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: adfc0d03-0c0e-40ac-b3ad-29e092e46214
API URL: JSON